Where Morphological and Molecular Classifications Meet: The Role of p53 Immunohistochemistry in the Prognosis of Low-Risk Endometrial Carcinoma (GLAMOUR Study)

Where Morphological and Molecular Classifications Meet: The Role of p53 Immunohistochemistry in the Prognosis of Low-Risk Endometrial Carcinoma (GLAMOUR Study)

No prospective study has validated molecular classification to guide adjuvant treatment in endometrial cancer (EC), and not even retrospective data are present for patients with morphological low-risk EC. We conducted a retrospective, multicenter, observational study including 370 patients with low-...

Full description

Bibliographic Details
Main Authors: Andrea Puppo, Giulio Fraternali Orcioni, Valentino Clignon, Yuri Musizzano, Carla Angela Zavattero, Giulia Vocino Trucco, Giacomo Maria Benazzo, Giuseppe Vizzielli, Stefano Restaino, Laura Mariuzzi, Maria Orsaria, Renato Seracchioli, Diego Raimondo, Linda Bertoldo, Stefano Uccella, Anna Caliò, Giulia Vittori Antisari, Simone Garzon, Vito Andrea Capozzi, Roberto Berretta, Francesco Cosentino, Alfredo Ercoli, Antonio Ieni, Martina Arcieri, Marcello Ceccaroni, Anna Pesci, Giulia Mantovani, Francesco Bruni, Giovanni Roviglione, Pio Zeppa, Antonio Raffone, Marco Camanni, Elena Maria Delpiano, Claudia Provenza, Martina Borghese, Giuseppe Migliaretti
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Cancers
Subjects:
endometrial cancer
molecular classification
p53
target therapy
Online Access:https://www.mdpi.com/2072-6694/16/6/1088

Internet

https://www.mdpi.com/2072-6694/16/6/1088

Similar Items